ClinicalTrials.Veeva

Menu

Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer

O

Ottawa Hospital Research Institute

Status

Completed

Conditions

Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01799980
2009471-01H

Details and patient eligibility

About

This study will compare two different methods of staging lung cancer to determine whether endobronchial ultrasound (EBUS) staging of mediastinal lymph nodes will provide good diagnostic yield in detecting lung cancer, when compared to current methods of a staging bronchoscopy and cervical mediastinoscopy.

Enrollment

37 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients, > 18 years of age,

Gender- Males and Female

Diagnosis of Non Small Cell Lung Cancer.

Patients who have consented on an Ottawa Hospital consent form to undergo a mediastinoscopy procedure or EBUS-TBNA, and a Positron emission tomography (PET) of the chest for lung cancer staging.

Exclusion criteria

Females who are pregnant (or found to be pregnant) during the course of this research study.

Patients who do not provide their Ottawa Hospital consent to undergo a staging bronchoscopy , cervical mediastinoscopy or EBUS-TBNA.

Trial design

37 participants in 2 patient groups

Cervical mediastinoscopy
Description:
This group will undergo cervical mediastinoscopy before surgery to stage their lung cancer (procedure decided by the surgeon).
Endo-bronchial ultrasound
Description:
This group will undergo endobronchial ultrasound before surgery to stage their lung cancer (procedure decided by the surgeon).

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems